Literature DB >> 10369336

More data about the new psychoactive drug 2C-B.

D de Boer, M J Gijzels, I J Bosman, R A Maes.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10369336     DOI: 10.1093/jat/23.3.227

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


× No keyword cloud information.
  4 in total

1.  Recurrent seizures and serotonin syndrome following "2C-I" ingestion.

Authors:  Adam Bosak; Frank LoVecchio; Michael Levine
Journal:  J Med Toxicol       Date:  2013-06

2.  Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.

Authors:  Tomáš Páleníček; Michaela Fujáková; Martin Brunovský; Jiří Horáček; Ingmar Gorman; Marie Balíková; Lukáš Rambousek; Kamila Syslová; Petr Kačer; Petr Zach; Věra Bubeníková-Valešová; Filip Tylš; Anna Kubešová; Jana Puskarčíková; Cyril Höschl
Journal:  Psychopharmacology (Berl)       Date:  2012-07-29       Impact factor: 4.530

3.  4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes.

Authors:  Claudio A Villalobos; Paulina Bull; Patricio Sáez; Bruce K Cassels; J Pablo Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

4.  Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines.

Authors:  T Montgomery; C Buon; S Eibauer; P J Guiry; A K Keenan; G J McBean
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.